Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Partial allelotype of carcinoma in situ of the human bladder.

Cancer research - 15 Nov 1995

Rosin M P, Cairns P, Epstein J I, Schoenberg M P, Sidransky D

Abstract excerpt

Carcinoma in situ (CIS) of the urinary bladder is an aggressive lesion that frequently progresses to an invasive tumor, yet the underlying molecular changes in this lesion are largely unknown. In this study, we microdissected 31 cases of CIS and examined them for loss of heterozygosity (LOH) on 13 chromosomal arms. Twenty-nine microsatellite markers were chosen for this analysis based on their location in regions...

Topics

Alleles
Carcinoma in Situ
Chromosome Deletion
Chromosomes, Human, Pair 9
Humans
Urinary Bladder Neoplasms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 7585577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-7585577-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Partial allelotype of carcinoma in situ of the human bladder.PMID 7585577Read ↗

Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.Semantic proximity Read ↗

Allelotype of human bladder cancer.Semantic proximity Read ↗

Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancerSemantic proximity Read ↗

Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia.Semantic proximity Read ↗

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.Semantic proximity Read ↗

Two molecular pathways to transitional cell carcinoma of the bladder.Semantic proximity Read ↗

Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.Semantic proximity Read ↗

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.Semantic proximity Read ↗

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.Semantic proximity Read ↗

Clinical significance of allelotype profiling for urothelial carcinoma.Semantic proximity Read ↗

Chromosomal changes in uroepithelial carcinomasSemantic proximity Read ↗

Analysis of genetic alterations in normal bladder urothelium.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.